ClinicalTrials.gg
RecruitingNCT07435935BMR-VITDUpdated Oct 6, 2026

Bone Myoregulation Reflex and Postural Control in Vitamin D Deficiency

An observational study in Vitamin D Deficiency, sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Istanbul Physical Medicine Rehabilitation Training and Research Hospital · Observational

From the registry’s dates

  • Started Mar 2026; still recruiting 8 months later.
Updated Oct 6, 2026Primary completion movedStudy completion movedGo to Updates ↓
Study type
Observational
Model
Case-control
Time perspective
Cross-sectional
Enrollment
24
Ages
20 Years to 40 Years
Sex
All
01

Study summary

This observational study aims to investigate the relationship between vitamin D deficiency, postural stability, and neuromuscular control mechanisms in adults. The study will compare individuals with vitamin D deficiency and healthy controls.

Participants will undergo a single-session evaluation including surface electromyography and postural stability assessments during standing tasks under different loading and vibration conditions. No invasive procedures, medications, or blood sampling will be performed. Previously obtained routine laboratory results will be used for vitamin D status.

The study is designed to improve understanding of neuromuscular responses associated with vitamin D deficiency and to contribute to future rehabilitation strategies.

Read the detailed description

This single-center observational study is designed to evaluate postural stability and load-sensitive neuromuscular control mechanisms in adults with vitamin D deficiency.

Participants will be divided into two groups based on their vitamin D status: individuals with vitamin D deficiency and healthy controls. Vitamin D levels will be determined using previously obtained routine laboratory test results. No additional blood sampling will be performed for this study.

All participants will undergo a standardized assessment protocol in a single session. Surface electromyography will be used to record muscle activity during standing tasks under different postural and loading conditions. Measurements will be performed during single-leg and double-leg stance, with and without vibration stimulation. The procedures are non-invasive and do not involve any pharmacological intervention.

Postural stability parameters and neuromuscular response variables will be analyzed and compared between groups. The primary objective is to identify potential differences in reflex modulation and postural control associated with vitamin D deficiency.

The study aims to provide objective data on neuromuscular adaptations related to vitamin D status and to support future research in rehabilitation and balance training.

02

Conditions studied

  • Vitamin D Deficiency

Browse trials for

Keywords

  • Vitamin D Deficiency
  • Postural Stability
  • Balance Control
  • Neuromuscular Control
  • Surface Electromyography
  • Reflex Modulation
  • Bone Myoregulation Reflex
  • Standing Balance
  • Rehabilitation Research
  • Postural Sway
03

In context

Vitamin D Deficiency

801 studies on the registry are indexed under Vitamin D Deficiency; 60 are open to participants now.

This study's planned enrollment of 24 is below the median of 138 across 185 observational studies indexed under Vitamin D Deficiency.

Browse Vitamin D Deficiency studies →

Lead sponsor

Istanbul Physical Medicine Rehabilitation Training and Research Hospital is the lead sponsor of 123 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Adults aged 20 to 40 years recruited from the outpatient clinics of Istanbul Physical Medicine and Rehabilitation Training and Research Hospital. Participants will include individuals with laboratory-confirmed vitamin D deficiency and healthy volunteers with normal vitamin D status.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 20 to 40 years.
  • Ability to provide written .
  • Vitamin D deficiency group: serum 25-hydroxyvitamin D level \<10 ng/mL measured within the last 3 months (routine clinical testing).
  • Healthy control group: normal vitamin D status based on routine clinical testing within the last 3 months.
  • No use of vitamin D or calcium supplementation within the last 3 months.

Exclusion criteria

Exclusion Criteria:

  • Known metabolic bone disease other than vitamin D deficiency.
  • Neurological disorder (central or peripheral) or neuromuscular disease.
  • History of lower-limb surgery, fracture, or prosthesis affecting standing balance.
  • Vestibular disorder.
  • >30 kg/m2.
  • Active .
  • Severe psychiatric disorder.
  • Skin condition preventing placement of surface EMG electrodes.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Case-control
Time perspective
Cross-sectional
Enrollment
24 participants (estimated)
Patient registry
No

Groups and cohorts

  • Vitamin D Deficiency Group

    Participants with laboratory-confirmed vitamin D deficiency based on routine clinical test results. All participants will undergo standardized non-invasive postural stability and surface electromyography assessments in a single session.

  • Healthy Control Group

    Participants with normal vitamin D status based on routine clinical test results and no history of balance or neuromuscular disorders. All participants will undergo standardized non-invasive postural stability and surface electromyography assessments in a single session.

06

What researchers measure

Primary outcomes

  1. Postural Stability Parameters

    Postural stability parameters measured during single-leg and double-leg standing using force platform and surface electromyography, including postural sway and neuromuscular response variables.

    Time frame: Single assessment session (baseline)

Secondary outcomes

  1. Neuromuscular Reflex and Muscle Activation Patterns

    Surface electromyography-derived muscle activation and reflex modulation parameters recorded under different loading and vibration conditions.

    Time frame: Single assessment session (baseline)

  2. Effect of Loading and Vibration on Postural Control

    Changes in postural stability and neuromuscular responses under loaded and unloaded conditions with and without vibration.

    Time frame: Single assessment session (baseline)

07

Study locations

1 of 1 sites recruiting
  • Istanbul Physical Medicine and Rehabilitation Training and Research Hospital
    Istanbul, 34186, Turkey (Türkiye)
    Recruiting
08

References and documents

Publications

  • Karacan I, Cakar HI, Sebik O, Yilmaz G, Cidem M, Kara S, Turker KS. A new method to determine reflex latency induced by high rate stimulation of the nervous system. Front Hum Neurosci. 2014 Jul 18;8:536. doi: 10.3389/fnhum.2014.00536. eCollection 2014. PubMed 25100978 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data will be shared upon reasonable request for academic and research purposes, after publication of the main results. Requests will be reviewed by the principal investigator and data will be provided under a data use agreement.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Supporting documents and de-identified individual participant data will be made available upon reasonable request after publication of the main results. Requests will be reviewed by the principal investigator and shared for academic purposes under a data use agreement.

Access criteria: Access to de-identified individual participant data and supporting documents (study protocol, statistical analysis plan, and informed consent form) will be granted to qualified researchers upon reasonable request for academic and non-commercial purposes. Requests will be reviewed by the principal investigator. Data will be shared through secure electronic transfer under a data use agreement.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Mar 2026 to primary completion in Sep 2026, 6 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: primary completion Jun 2026 → Sep 2026 and completion Jul 2026 → Oct 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 21, 2026
First posted
Feb 27, 2026
StartActual
Mar 5, 2026
Primary completionActual
Sep 25, 2026was Jun 2026
CompletionEst.
Oct 25, 2026was Jul 2026
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Jun 5, 2026→Sep 25, 2026 (actual)
Oct 6, 2026
Study completion
Jul 5, 2026→Oct 25, 2026
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    Primary completion Jun 5, 2026→Sep 25, 2026 (now actual)
    Study completion Jul 5, 2026→Oct 25, 2026

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07435935
Responsible party
Selim Sezikli (Specialist in Physical Medicine and Rehabilitation, Istanbul Physical Medicine Rehabilitation Training and Research Hospital) — Principal investigator
First posted
Feb 27, 2026
Start date
Mar 5, 2026
Primary completion
Sep 25, 2026
Completion
Oct 25, 2026 (estimated)
Last update
Oct 6, 2026

Study contacts

Selim Sezikli, MD
Contact
selimsezikli@hotmail.com
+905065101833
Ilhan Karacan, Prof.
Contact
mdkaracanilhan@gmail.com
+905327005361
Selim Sezikli, MD
principal investigator · Istanbul Physical Medicine and Rehabilitation Training and Research Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion